Pressure Support Ventilation During Laparoscopic and Abdominal Robotic Surgery.
1 other identifier
interventional
106
1 country
1
Brief Summary
This study is a single-center, blind, prospective, randomized, controlled trial of pressure support ventilation (PSVpro) versus pressure control ventilation - volume guaranteed (PCV - VG) during laparoscopic and robotic abdominal surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2017
CompletedFirst Submitted
Initial submission to the registry
October 28, 2020
CompletedFirst Posted
Study publicly available on registry
March 25, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2023
CompletedApril 26, 2023
April 1, 2023
5.8 years
October 28, 2020
April 25, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Concentrations of biomarkers of lung injury
Measure concentration of Interleukin-6 (IL-6), Interleukin-8 (IL-8), tumor necrosis factor receptor I / II (sTNF rI / II)) in blood serum
1-3 hours after surgery
Secondary Outcomes (2)
Maximum intraoperative lactate level in the early postoperative period
1 hour after surgery
The maximum level of vasopressor support during surgery
From time of skin incision to time of skin closure assessed up to 24 hours
Other Outcomes (19)
Duration of anaesthesia.
Period of time from induction to volatile anesthetic supply stop assessed up to 24 hours
Procedure time
Period of time from intubation to extubation assessed up to 24 hours
Length of stay (LOS) in the intensive care unit (ICU).
Period of time from ICU arrival to discharge from ICU assessed up to 1 year
- +16 more other outcomes
Study Arms (2)
Mandatory ventilation
ACTIVE COMPARATORdeep neuromuscular block and mandatory ventilation (PCV-VG);
Pressure support ventilation
EXPERIMENTALpartial neuromuscular block and pressure support ventilation (PSVpro).
Interventions
Eligibility Criteria
You may qualify if:
- Written consent.
- Men and women aged 18 years or more.
- The physical status from ASA classification I, II or III.
- BMI \<= 34.9 kg / m2.
- Low risk of respiratory complications.
- Laparoscopic surgery in the pelvis.
You may not qualify if:
- The physical status from ASA IV or V.
- BMI\> = 35 kg / m2.
- Neuromuscular disease.
- Allergy to Anesthetic Agents.
- Operations on two cavities.
- Operations on the chest cavity.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Moscow Clinical Scientific Center
Moscow, Russia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
October 28, 2020
First Posted
March 25, 2021
Study Start
June 1, 2017
Primary Completion
March 31, 2023
Study Completion
March 31, 2023
Last Updated
April 26, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share